Frontiers in immunology · 2026
IL-33 induces stronger responses in female mast cells and neutrophils: a role for the JNK pathway.
СтатьяПоддержка NIH: внешняя программаНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kee Sydney Ann, Maldonado Tania D, Ching John M, Nelson Catherine, Hussain Zakaria Y, Yao An Z, Kotha Aditya, Hamze Hadi, Burchett Jason R, Ryan John J
Аннотация
INTRODUCTION: Allergic diseases exhibit considerable sex-based variations, with greater incidence of allergic asthma, atopic dermatitis, food allergy, and chronic urticaria among adult females. This female dominance may be explained by differences in inflammatory signaling.
METHODS: We used primary mouse mast cells, neutrophils, and eosinophils as well as two mouse models of IL-33-induced inflammation to measure male and female responses to IL-33.
RESULTS: We show that the allergy-associated cytokine IL-33 elicits stronger responses from female mast cells and neutrophils compared to males, both in vitro and in vivo. The greater female response was not due to increased expression or sensitivity of the IL-33 receptor in female cells. Instead, we noted female-selective activation of the JNK pathway in response to IL-33. Male and female mast cells both required the ERK, p38, NF-kB, and AP-1 pathways to produce inflammatory cytokines in response to IL-33. However, inhibiting the JNK pathway selectively reduced IL-33-mediated cytokine production in female mast cells. A mast cell-dependent model of IL-33-induced peritonitis showed that gonadectomy ablated sexual dimorphism in the neutrophil influx response. However, plasma IL-13 levels remained higher in females even among mice lacking sex organs.
DISCUSSION: These data show that IL-33 induces female-dominant mast cell and neutrophil responses, partly via female-selective JNK signaling.
METHODS: We used primary mouse mast cells, neutrophils, and eosinophils as well as two mouse models of IL-33-induced inflammation to measure male and female responses to IL-33.
RESULTS: We show that the allergy-associated cytokine IL-33 elicits stronger responses from female mast cells and neutrophils compared to males, both in vitro and in vivo. The greater female response was not due to increased expression or sensitivity of the IL-33 receptor in female cells. Instead, we noted female-selective activation of the JNK pathway in response to IL-33. Male and female mast cells both required the ERK, p38, NF-kB, and AP-1 pathways to produce inflammatory cytokines in response to IL-33. However, inhibiting the JNK pathway selectively reduced IL-33-mediated cytokine production in female mast cells. A mast cell-dependent model of IL-33-induced peritonitis showed that gonadectomy ablated sexual dimorphism in the neutrophil influx response. However, plasma IL-13 levels remained higher in females even among mice lacking sex organs.
DISCUSSION: These data show that IL-33 induces female-dominant mast cell and neutrophil responses, partly via female-selective JNK signaling.